These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 23755557)
21. [Mono- and Binuclear Dinitrosyl Iron Complexes with Thiol-containing Ligands in Various Biosystems]. Vanin AF; Mikoyan VD; Kubrina LN; Borodulin RR; Burgova EN Biofizika; 2015; 60(4):735-47. PubMed ID: 26394474 [TBL] [Abstract][Full Text] [Related]
22. The Inhibiting Effect of Dinitrosyl Iron Complexes with Thiol-containing Ligands on the Growth of Endometrioid Tumours in Rats with Experimental Endometriosis. Burgovа EN; Khristidis YI; Kurkov AV; Mikoyan VD; Shekhter AB; Adamyan LV; Timashev PS; Vanin AF Cell Biochem Biophys; 2019 Mar; 77(1):69-77. PubMed ID: 30710220 [TBL] [Abstract][Full Text] [Related]
23. Nitrosonium Cation as a Cytotoxic Component of Dinitrosyl Iron Complexes with Thiol-containing Ligands (based on the Experimental Work on MCF7 Human Breast Cancer Cell Culture). Vanin AF; Tronov VA; Borodulin RR Cell Biochem Biophys; 2021 Mar; 79(1):93-102. PubMed ID: 33492647 [TBL] [Abstract][Full Text] [Related]
24. [Hypotensive effect of dinitrosyl iron complexes in experiments on waking animals]. Galagan ME; Oranovskaia EV; Mordvintsev PI; Medvedev OS; Vanin AF Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):75-80. PubMed ID: 2852943 [TBL] [Abstract][Full Text] [Related]
25. Vasorelaxing activity of stable powder preparations of dinitrosyl iron complexes with cysteine or glutathione ligands. Vanin AF; Mokh VP; Serezhenkov VA; Chazov EI Nitric Oxide; 2007 May; 16(3):322-30. PubMed ID: 17258478 [TBL] [Abstract][Full Text] [Related]
26. The 2.03 signal as an indicator of dinitrosyl-iron complexes with thiol-containing ligands. Vanin AF; Serezhenkov VA; Mikoyan VD; Genkin MV Nitric Oxide; 1998; 2(4):224-34. PubMed ID: 9851363 [TBL] [Abstract][Full Text] [Related]
27. Interaction of peroxynitrite and hydrogen peroxide with dinitrosyl iron complexes containing thiol ligands in vitro. Lobysheva II; Serezhenkov VA; Vanin AF Biochemistry (Mosc); 1999 Feb; 64(2):153-8. PubMed ID: 10187905 [TBL] [Abstract][Full Text] [Related]
28. [Physico-chemical features of dinitrosyl iron complexes with natural thiol-containing ligands underlying biological activities of these complexes]. Vanin AF; Borodulin RR; Kubrina LN; Mikoian VD; Burbaev DSh Biofizika; 2013; 58(1):126-36. PubMed ID: 23650863 [TBL] [Abstract][Full Text] [Related]
29. Dinitrosyl iron complexes with thiolate ligands: physico-chemistry, biochemistry and physiology. Vanin AF Nitric Oxide; 2009 Aug; 21(1):1-13. PubMed ID: 19366636 [TBL] [Abstract][Full Text] [Related]
30. Activation of soluble guanylate cyclase by NO donors--S-nitrosothiols, and dinitrosyl-iron complexes with thiol-containing ligands. Severina IS; Bussygina OG; Pyatakova NV; Malenkova IV; Vanin AF Nitric Oxide; 2003 May; 8(3):155-63. PubMed ID: 12826064 [TBL] [Abstract][Full Text] [Related]
31. [Why does iron abrogate the cytotoxic effect of S-nitrosothiols on human and animal cultured cells?]. Serezhenkov VA; Kalinina EV; Glazunova VA; Saprin AN; Vanin AF Biofizika; 2007; 52(5):869-75. PubMed ID: 17969921 [TBL] [Abstract][Full Text] [Related]
32. Dinitrosyl iron complexes (DNICs) bearing O-bound nitrito ligand: reversible transformation between the six-coordinate {Fe(NO)2}9 [(1-MeIm)2(eta(2)-ONO)Fe(NO)2] (g = 2.013) and four-coordinate {Fe(NO)2}9 [(1-MeIm)(ONO)Fe(NO)2] (g = 2.03). Tsai FT; Kuo TS; Liaw WF J Am Chem Soc; 2009 Mar; 131(10):3426-7. PubMed ID: 19226176 [TBL] [Abstract][Full Text] [Related]
33. [Study of dinitrosyl-iron complexes pharmacokinetics and accumulation in depot in rat organs]. Timoshin AA; Lakomkin VL; Ruuge ÉK; Vanin AF Biofizika; 2012; 57(2):331-7. PubMed ID: 22594291 [TBL] [Abstract][Full Text] [Related]
34. [Transformations of dinitrosyl iron complexes in an isolated rat heart after introduction of this substance into perfusion medium]. Timoshina AA; Lakomkin VL; Drobotova DIu; Ruuge EK; Vanin AF Biofizika; 2013; 58(2):281-8. PubMed ID: 23755555 [TBL] [Abstract][Full Text] [Related]
35. [Inhibition of platelet aggregation by dinitrosyl iron complexes with low molecular weight ligands]. Mordvintsev PI; Rudneva VG; Vanin AF; Shimkevich LL; Khodorov BI Biokhimiia; 1986 Nov; 51(11):1851-7. PubMed ID: 3026500 [TBL] [Abstract][Full Text] [Related]
36. Dinitrosyl iron complexes with thiol-containing ligands and apoptosis: studies with HeLa cell cultures. Giliano NY; Konevega LV; Noskin LA; Serezhenkov VA; Poltorakov AP; Vanin AF Nitric Oxide; 2011 Apr; 24(3):151-9. PubMed ID: 21354319 [TBL] [Abstract][Full Text] [Related]
37. Relative binding affinity of thiolate, imidazolate, phenoxide, and nitrite toward the {Fe(NO)2} motif of dinitrosyl iron complexes (DNICs): the characteristic pre-edge energy of {Fe(NO)2}9 DNICs. Tsai MC; Tsai FT; Lu TT; Tsai ML; Wei YC; Hsu IJ; Lee JF; Liaw WF Inorg Chem; 2009 Oct; 48(19):9579-91. PubMed ID: 19746902 [TBL] [Abstract][Full Text] [Related]
38. Dinitrosyl iron complexes (DNICs) containing S/N/O ligation: transformation of Roussin's red ester into the neutral {Fe(NO)2}10 DNICs. Tsai ML; Hsieh CH; Liaw WF Inorg Chem; 2007 Jun; 46(12):5110-7. PubMed ID: 17444639 [TBL] [Abstract][Full Text] [Related]
39. Dinitrosyl iron complexes bind with hemoglobin as markers of oxidative stress. Shumaev KB; Kosmachevskaya OV; Timoshin AA; Vanin AF; Topunov AF Methods Enzymol; 2008; 436():445-61. PubMed ID: 18237648 [TBL] [Abstract][Full Text] [Related]